The size of the North America Biobanks Market was valued at USD 66.92 million in 2021 and is forecasted to worth USD 93.51 million by 2026, increasing at a CAGR of 6.92% between 2021 to 2026.
The biobank is basically a type of biorepository which stores the biological samples (mainly human samples) used for research purposes or even for treatment. Geographically North America leads the market with the highest number of shares. Factors driving the market are the increasing rate of diseased and aged population and the recent advancements in the field of molecular biology and genetics, which requires a large number of specimens.
Biobanks play a vital role in the field of biomedical research. The wide range of biospecimens includes samples of blood, saliva, plasma, and purified DNA, which can be described as libraries of the human organism.
North American researchers depend more on biobanks for providing samples. For therapeutics and the industrial development of diagnostics and medical research, biological material and related data have become an important resource. An increase in demand for tissue banking, stem cell banking, and umbilical cord banking is the reason for inclination in the North American market for Biopreservation systems due to an increase.
The key driver for the North America Biobanks Market is the pharmaceutical industry's poor productivity rate concerning new drug approvals. These storage solutions can reduce the testing time and costs for manufacturers, as a testing laboratory can take up to 3 days for testing. Still, if the hospital themselves have the storage bank, the time can reduce to 3 hours.
The major drawbacks involve storage and handling problem, regulatory issues, and cost-competitive procedures. Privacy and confidential issues are as well restraining the market.
This research report on the North American Biobanks market has been segmented and sub-segmented into the following categories:
By Product Type:
By Sample Type:
By Application:
By Country:
The human tissue section is expected to account for the highest market share of approximately 65% during the forecast period based on the sample type. Preference for human tissue specimens increases over animal tissue samples due to the unavailability of appropriate animal models for some specific neurological and psychiatric disorders.
Companies playing a dominant role in the North America Biobanks Market profiled in this report are Beckman Coulter, Tecan group, Taylor- Wharton, Panasonic biomedical, Teva Pharmaceuticals, Biolife Solutions, Custom biogenic systems, Princeton cryotech, Fluidx, Tissue solutions, Wildcat laboratory solutions, Micronik and Brooks life science systems.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Equipment’s
5.1.1.1 Temperature control systems
5.1.1.2 Incubators
5.1.1.3 Centrifuges
5.1.1.4 Alarm and Monitoring Systems
5.1.1.5 Accessories
5.1.1.6 Other Equipment's
5.1.2 Consumables
5.2 By Sample Type
5.2.1 Human Tissues
5.2.2 Stem Cells
5.2.3 DNA or RNA
5.2.4 Bio-fluids
5.2.5 Other Sample Type
5.3 By Application
5.3.1 Therapeutic Applications
5.3.2 Research Applications
5.3.3 Clinical Trials
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Beckman Coulter
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Tecan group
8.3 Taylor- Wharton
8.4 Panasonic biomedical
8.5 Teva pharmaceuticals
8.6 Biolife solutions
8.7 Custom biogenic systems
8.8 Princeton cryotech
8.9 Fluidx
8.10 Tissue solutions
8.11 Wildcat laboratory solutions
8.12 Micronik
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
